• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例经新辅助化疗及后续手术成功治疗的腹膜后去分化脂肪肉瘤病例。

A case of retroperitoneal dedifferentiated liposarcoma successfully treated by neoadjuvant chemotherapy and subsequent surgery.

作者信息

Yokoyama Yukihiro, Nishida Yoshihiro, Ikuta Kunihiro, Nagino Masato

机构信息

Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Department of Orthopedics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

出版信息

Surg Case Rep. 2020 May 24;6(1):105. doi: 10.1186/s40792-020-00865-2.

DOI:10.1186/s40792-020-00865-2
PMID:32448975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7246274/
Abstract

BACKGROUND

Retroperitoneal liposarcoma (RPLS) is the most commonly observed soft tissue sarcoma in the retroperitoneal space. Although the beneficial effect of chemotherapy for RPLS is controversial, there are some reports that have shown a considerable tumor-suppressive effect of chemotherapy in RPLS. We demonstrate a case of dedifferentiated RPLS, which was initially considered inoperable but was successfully treated by neoadjuvant chemotherapy and subsequent curative resection.

CASE PRESENTATION

A 59-year-old female was referred to our hospital with a chief complaint of right lower quadrant abdominal pain. Abdominal computed tomography revealed a large retroperitoneal tumor with a maximum diameter of 11 cm. The tumor involved retroperitoneal major vasculatures, such as the right common iliac vein and artery, as well as the right psoas muscle and femoral nerve. The right ureter was also involved and obstructed by the tumor. A biopsy was performed through the retroperitoneal route, and the tumor was diagnosed as a dedifferentiated liposarcoma with the Fédération Nationale des Centres de Lutte Contre le Cancer grade 3. Because the tumor was highly invasive and complete resection was not feasible, we decided to administer neoadjuvant chemotherapy with doxorubicin and ifosfamide (AI). After completing 6 courses of AI, the tumor size was considerably reduced, and we decided to perform surgery with curative intent. Before laparotomy, femoro-femoral arterial bypass was performed to prepare for the right common iliac artery resection. Thereafter, the patient underwent laparotomy and tumor resection combined with right nephrectomy, resection of the right common iliac artery and vein, and resection of the right psoas muscle and femoral nerve. The postoperative course was uneventful, although the patient needed a walking brace to support her gait. The pathological findings indicated a 99% disappearance of tumor cells. The patient was healthy without any complaints after 1 year of surgery, and a follow-up CT scan revealed no tumor recurrence.

CONCLUSIONS

To the best of our knowledge, this is the first report that showed a nearly complete pathological response to AI in dedifferentiated RPLS, which was subsequently completely resected.

摘要

背景

腹膜后脂肪肉瘤(RPLS)是腹膜后间隙最常见的软组织肉瘤。尽管化疗对RPLS的有益效果存在争议,但有一些报告显示化疗对RPLS有相当显著的肿瘤抑制作用。我们展示了一例去分化型RPLS病例,该病例最初被认为无法手术,但通过新辅助化疗及随后的根治性切除成功得到治疗。

病例介绍

一名59岁女性因右下腹痛为主诉转诊至我院。腹部计算机断层扫描显示一个最大直径为11厘米的巨大腹膜后肿瘤。该肿瘤累及腹膜后主要血管,如右髂总静脉和动脉,以及右腰大肌和股神经。右侧输尿管也被肿瘤累及并阻塞。通过腹膜后途径进行了活检,肿瘤被诊断为法国国立癌症中心联合会3级的去分化脂肪肉瘤。由于肿瘤具有高度侵袭性且无法进行完整切除,我们决定给予多柔比星和异环磷酰胺(AI)新辅助化疗。完成6个疗程的AI治疗后,肿瘤大小显著缩小,我们决定进行根治性手术。在剖腹手术前,进行了股-股动脉搭桥术,为切除右髂总动脉做准备。此后,患者接受了剖腹手术及肿瘤切除术,同时进行了右肾切除术、右髂总动脉和静脉切除术以及右腰大肌和股神经切除术。术后过程顺利,尽管患者需要步行支架来辅助步态。病理结果显示肿瘤细胞消失了99%。术后1年患者健康无任何不适,随访CT扫描未发现肿瘤复发。

结论

据我们所知,这是第一份显示去分化型RPLS对AI有近乎完全病理反应且随后得以完全切除的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/7452537e3369/40792_2020_865_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/33da0917e865/40792_2020_865_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/b5f1958fe8dd/40792_2020_865_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/8ba8caee403b/40792_2020_865_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/92721360cebd/40792_2020_865_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/48db881f3475/40792_2020_865_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/7452537e3369/40792_2020_865_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/33da0917e865/40792_2020_865_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/b5f1958fe8dd/40792_2020_865_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/8ba8caee403b/40792_2020_865_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/92721360cebd/40792_2020_865_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/48db881f3475/40792_2020_865_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6215/7246274/7452537e3369/40792_2020_865_Fig6_HTML.jpg

相似文献

1
A case of retroperitoneal dedifferentiated liposarcoma successfully treated by neoadjuvant chemotherapy and subsequent surgery.一例经新辅助化疗及后续手术成功治疗的腹膜后去分化脂肪肉瘤病例。
Surg Case Rep. 2020 May 24;6(1):105. doi: 10.1186/s40792-020-00865-2.
2
A long-term survivor of advanced retroperitoneal dedifferentiated liposarcoma: a successful multimodal approach with extended resection and chemotherapy.晚期腹膜后去分化脂肪肉瘤的长期幸存者:成功的多模式治疗方法,包括扩大切除术和化疗。
Nagoya J Med Sci. 2022 Feb;84(1):200-207. doi: 10.18999/nagjms.84.1.200.
3
Perioperative strategy and outcome in giant retroperitoneal dedifferentiated liposarcoma-results of a retrospective cohort study.巨大腹膜后去分化脂肪肉瘤的围手术期策略与结局——一项回顾性队列研究的结果
World J Surg Oncol. 2020 Nov 12;18(1):296. doi: 10.1186/s12957-020-02069-2.
4
Case report and literature review: Conversion surgery for initially unresectable huge retroperitoneal liposarcoma after preoperative radiotherapy.病例报告及文献综述:术前放疗后对初始不可切除的巨大腹膜后脂肪肉瘤进行转化手术。
Front Oncol. 2023 Jan 6;12:1096411. doi: 10.3389/fonc.2022.1096411. eCollection 2022.
5
A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study.对于腹膜后脂肪肉瘤患者,全(同侧)腹膜后脂肪切除术的总生存期(OS)优于标准根治性切除术:一项多机构比较研究。
Ann Transl Med. 2022 Jul;10(14):785. doi: 10.21037/atm-22-3332.
6
Primary dedifferentiated Liposarcoma of vagina: a first case report.阴道原发性去分化脂肪肉瘤:首例报告。
Diagn Pathol. 2021 Jan 9;16(1):3. doi: 10.1186/s13000-020-01062-3.
7
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].[以手术为中心的多模式治疗复发性腹膜后脂肪肉瘤伴肺转移:1例报告]
Nihon Hinyokika Gakkai Zasshi. 2018;109(1):25-29. doi: 10.5980/jpnjurol.109.25.
8
[Retroperitoneal Dedifferentiated Liposarcoma with No Recurrence after 5 Years of Postoperative Radiation Therapy --A Case Report-].[腹膜后去分化脂肪肉瘤术后放疗5年无复发——病例报告]
Hinyokika Kiyo. 2023 Mar;69(3):79-83. doi: 10.14989/ActaUrolJap_69_3_79.
9
[A Case of Giant Retroperitoneal Liposarcoma Resected after Trabectedin Chemotherapy].[1例曲贝替定化疗后切除的巨大腹膜后脂肪肉瘤病例]
Gan To Kagaku Ryoho. 2018 Dec;45(13):2132-2134.
10
Huge retroperitoneal dedifferentiated liposarcoma presented as acute pancreatitis: report of a case.巨大腹膜后去分化脂肪肉瘤表现为急性胰腺炎:一例报告
J Med Invest. 2013;60(1-2):164-8. doi: 10.2152/jmi.60.164.

引用本文的文献

1
Integrative In-Silico Analysis of Retroperitoneal Tumors in Colorectal Surgery: Advancements and Implications.结直肠手术中腹膜后肿瘤的整合计算机模拟分析:进展与影响
Cell Biochem Biophys. 2025 Apr 16. doi: 10.1007/s12013-025-01733-2.
2
Giant retroperitoneal myolipoma mimicking liposarcoma: report of a resected case and review of the literature.酷似脂肪肉瘤的巨大腹膜后髓脂肪瘤:1例切除病例报告及文献复习
Int Cancer Conf J. 2024 Feb 5;13(2):144-152. doi: 10.1007/s13691-024-00655-9. eCollection 2024 Apr.
3
Survival of a patient with multiple-recurrent giant retroperitoneal dedifferentiated liposarcoma for 15 years: A case report.

本文引用的文献

1
Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments.腹膜后肿瘤的临床特征和手术治疗效果:多科室综合数据采集。
Int J Clin Oncol. 2020 May;25(5):929-936. doi: 10.1007/s10147-020-01620-1. Epub 2020 Jan 16.
2
Experience with eribulin in pretreated patients with advanced liposarcoma: a case series.预处理的高级脂肪肉瘤患者使用艾立布林的经验:病例系列。
Future Oncol. 2020 Jan;16(1s):25-32. doi: 10.2217/fon-2019-0599. Epub 2019 Dec 20.
3
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center.
一名复发性巨大腹膜后去分化脂肪肉瘤患者生存15年:病例报告
Front Surg. 2022 Nov 7;9:916802. doi: 10.3389/fsurg.2022.916802. eCollection 2022.
4
Giant retroperitoneal dedifferentiated liposarcoma mimicking ovarian cancer: A case report.酷似卵巢癌的巨大腹膜后去分化脂肪肉瘤:一例报告
Gynecol Oncol Rep. 2022 Oct 18;44:101088. doi: 10.1016/j.gore.2022.101088. eCollection 2022 Dec.
5
Prediction of intraoperative bleeding and blood transfusion in patients with recurrent retroperitoneal liposarcoma: a retrospective study.复发性腹膜后脂肪肉瘤患者术中出血及输血的预测:一项回顾性研究。
Ann Transl Med. 2022 Sep;10(18):986. doi: 10.21037/atm-22-4222.
6
Giant retroperitoneal liposarcoma treated with radical conservative surgery: A case report and review of literature.根治性保守手术治疗巨大腹膜后脂肪肉瘤:1例报告并文献复习
World J Clin Cases. 2022 Jul 6;10(19):6636-6646. doi: 10.12998/wjcc.v10.i19.6636.
7
Giant Retroperitoneal Mass: Case Report in a Primary Hospital and Review of the Literature.巨大腹膜后肿物:一家基层医院的病例报告及文献复习
Maedica (Bucur). 2022 Mar;17(1):226-229. doi: 10.26574/maedica.2022.17.1.226.
8
A long-term survivor of advanced retroperitoneal dedifferentiated liposarcoma: a successful multimodal approach with extended resection and chemotherapy.晚期腹膜后去分化脂肪肉瘤的长期幸存者:成功的多模式治疗方法,包括扩大切除术和化疗。
Nagoya J Med Sci. 2022 Feb;84(1):200-207. doi: 10.18999/nagjms.84.1.200.
9
Management of retroperitoneal sarcoma involving the iliac artery: Single-center surgical experience.累及髂动脉的腹膜后肉瘤的治疗:单中心手术经验
World J Clin Cases. 2022 Jan 21;10(3):811-819. doi: 10.12998/wjcc.v10.i3.811.
10
Synchronous Occurrence of Advanced Gastric Carcinoma with Retroperitoneal Liposarcoma: A Case Report.胃高级别癌与腹膜后脂肪肉瘤同时发生:一例报告。
Am J Case Rep. 2022 Jan 8;23:e934586. doi: 10.12659/AJCR.934586.
三级转诊中心晚期脂肪肉瘤患者的回顾性分析。
Oncol Res Treat. 2019;42(7-8):396-404. doi: 10.1159/000500608. Epub 2019 Jun 6.
4
Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.帕唑帕尼治疗晚期中高级别脂肪肉瘤患者。
Expert Opin Investig Drugs. 2019 Jun;28(6):505-511. doi: 10.1080/13543784.2019.1607291. Epub 2019 Apr 22.
5
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.腹膜后脂肪肉瘤的放射治疗:来自跨大西洋腹膜后肉瘤工作组的报告。
Cancer. 2019 Apr 15;125(8):1290-1300. doi: 10.1002/cncr.31927. Epub 2019 Jan 2.
6
A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.腰骶部原始未分化多形性肉瘤伴 LMNA-NTRK1 基因融合,对克唑替尼有持久的临床反应:病例报告。
BMC Cancer. 2018 Aug 22;18(1):842. doi: 10.1186/s12885-018-4749-z.
7
Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.腹膜后肉瘤的新辅助和辅助治疗策略。
Eur J Surg Oncol. 2018 May;44(5):571-579. doi: 10.1016/j.ejso.2018.02.001. Epub 2018 Feb 9.
8
Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy.腹膜后软组织肉瘤的术后监测:肿瘤组织学在指导策略中的重要性。
J Surg Oncol. 2018 Jan;117(1):99-104. doi: 10.1002/jso.24927. Epub 2017 Nov 28.
9
External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis.可切除软组织肉瘤的外照射放疗:系统评价和荟萃分析。
Ann Surg Oncol. 2018 Mar;25(3):754-767. doi: 10.1245/s10434-017-6081-2. Epub 2017 Sep 11.
10
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.软组织肉瘤的新辅助化疗:最新证据及临床意义
Ther Adv Med Oncol. 2017 Jun;9(6):415-429. doi: 10.1177/1758834017705588. Epub 2017 Apr 16.